Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

January 20, 2021
Open Access

Amino acids are sensitive glucagon receptor-specific biomarkers for glucagon-like peptide-1 receptor/glucagon receptor dual agonists

Diabetes, Obesity & Metabolism
Wenyu LiRaul C Camacho
January 17, 2021
Open Access

GLP-1 and hunger modulate incentive motivation depending on insulin sensitivity in humans

Molecular Metabolism
Ruth HanssenMarc Tittgemeyer
January 20, 2021
Open Access

Exposure to glucagon-like peptide 1 receptor (GLP-1R) agonists reduces glaucoma risk.

MedRxiv : the Preprint Server for Health Sciences
J. SterlingBrian L. VanderBeek
January 22, 2021

Explaining Divergent Observations Regarding Osteocalcin/GPRC6A Endocrine Signaling.

Min PiL Darryl Quarles
January 16, 2021

The Glucagon-Like Peptide-1 (GLP-1) Analog Exenatide Ameliorates Intrauterine Adhesions in Mice

Xiao-Ling MaYi-Qing Wang
January 16, 2021

The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes

European Journal of Endocrinology
Niels B DalsgaardFilip K Knop
January 19, 2021
Open Access

The Effect of Counterions in Hydrophobic Ion Pairs on Oral Bioavailability of Exenatide

ACS Biomaterials Science & Engineering
Thi Nhu Quynh PhanAndreas Bernkop-Schnürch
January 16, 2021

Design and Evaluation of Peptide Dual-Agonists of GLP-1 and NPY2 Receptors for Glucoregulation and Weight Loss with Mitigated Nausea and Emesis

Journal of Medicinal Chemistry
Brandon T MillikenRobert P Doyle
January 20, 2021

An overview of the current management of short-bowel syndrome in pediatric patients

Surgery Today
Mitsuru MutoSatoshi Ieiri
January 20, 2021

Extending our understanding of exenatide: a rare case of angio-oedema

BMJ Case Reports
Faisal MahfoozMegan Reichmuth
January 14, 2021
Open Access

Current Perspectives on Management of Type 2 Diabetes in Youth

Sachi Singhal, Seema Kumar
January 21, 2021

Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study.

Diabetes Care
Lawrence BlondeVanita R Aroda

Sign up to follow this feed and discover related papers.

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.


Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

© 2021 Meta ULC. All rights reserved